Jinghua Chen

Jinghua Chen, MD, PhD

Assistant Professor

Department: MD-OPHTHALMOLOGY

About Jinghua Chen

My name is Dr. Jinghua Chen and I graduated with M.D. and Ph.D. degrees from the Health Science Center of Peking University. I was inspired to pursue ophthalmology from Helen Keller and her quote, “keep your face to the sunshine and you cannot see the shadow.” The story of Helen Keller, a famous American author, disability rights advocate, lecturer, the first deafblind person to earn a Bachelor of Arts degree, inspired me to devote my whole life to clinical and research work in ophthalmology. I hope my work can bring light to thousands of patients with eye diseases.

After graduation I worked as an attending physician at the Second Teaching Hospital of Peking University. Subsequently, I completed a research fellowship at Massachusetts Eye and Ear Infirmary, Harvard University. The next step on my career journey was an ophthalmology residency at the University of Louisville, Kentucky, and Vitreoretinal fellowship training at the University of Texas Southwestern Medical Center.

I have a long -term goal to be an excellent surgeon, clinician, scientist and educator. I want to treat vitreoretinal diseases with my knowledge, skills and invention. I consider eye diseases, systemic diseases and patients as a whole system. When I manage the diseases, I would like to restore the balance of the whole system. I take care of my patients with my heart. I worked as the head surgeon for the Boston Retinal Implant. The target diseases of retinal implant are end stage retinitis pigmentosa and advanced age-related macular degeneration. I hope in the future this can restore vision for the blind.

As an ophthalmologist and vitreoretinal surgeon, my clinical interests include inherited retinal diseases, retinopathy of prematurity, age related macular degeneration, diabetic retinopathy and retinal detachment. I would like to improve the efficacy of the current gene delivery system and reduce the inflammation which is caused by gene therapy. I am also working on using artificial intelligence in early detecting, telemedicine screening and early intervention to prevent and manage the retinal disease of premature babies.

My research interests include retinal implant/visual prosthesis and inherited retinal diseases. Ophthalmology field is a combination of medicine, science and art. It was the enthusiasm of many dedicated ophthalmologists, specialists and vision science researchers who made this field fun and exciting. I love retina. Vitreoretinal surgeries make me feel happy, excited and challenged. This is an everchanging field with many new treatments including artificial retina, gene therapy, stem cell therapy and new medications to treat age related macular degeneration, diabetic retinopathy, inherited retinal diseases and other vitreoretinal diseases.

When I am not pursuing my passion of ophthalmology, I like to play badminton, to travel and to cook.

Accomplishments

Rabb-Venable Fellow Award
2016 · National Medical Association Annual Convention & Scientific Assembly
Excellent Young Teacher Award
2000 · Beijing University Health Science Center
Excellent Teacher Award
1999 · People's Hospital of Peking University
Excellent Graduate Student Award
1998 · Beijing University Health Science Center

Teaching Profile

Courses Taught
2021,2023
PAS5010 Intro to Medicine 1

Board Certifications

  • Ophthalmology
    American Board of Ophthalmology

Clinical Profile

Specialties
  • Ophthalmology
Subspecialties
  • Retina and Vitreous Care
Areas of Interest
  • Endophthalmitis
  • Ophthalmoscopy
  • Retinal artery occlusion
  • Retinal detachment
  • Retinal detachment repair
  • Retinal vein occlusion
  • Uveitis

Research Profile

Inherited retinal diseases Gene therapy Retinal implant

Open Researcher and Contributor ID (ORCID)

0000-0002-4092-7009

Areas of Interest
  • Adeno-Associated Viral Gene Therapy
  • Diabetic Retinopathy

Publications

2024
Quality of life analysis in patients with retinitis pigmentosa
Ophthalmic Research. [DOI] 10.1159/000539116.
2023
Application of Artificial Intelligence in the Early Detection of Retinopathy of Prematurity: Review of the Literature
Neonatology. 120(5):558-565 [DOI] 10.1159/000531441.
2023
Progressive Central Artery Occlusion, Ophthalmic Artery Occlusion, and Hemispheric Intracranial Thrombosis after COVID-19 mRNA Vaccine Application: Case Report
Case Reports in Ophthalmology. 173-179 [DOI] 10.1159/000529770. [PMID] 37089276.
2020
Implantation and Extraction of Penetrating Electrode Arrays in Minipig Retinas.
Translational vision science & technology. 9(5) [DOI] 10.1167/tvst.9.5.19. [PMID] 32821491.
2020
Micro-Fabrication of Components for a High-Density Sub-Retinal Visual Prosthesis.
Micromachines. 11(10) [DOI] 10.3390/mi11100944. [PMID] 33086504.
2011
A hermetic wireless subretinal neurostimulator for vision prostheses.
IEEE transactions on bio-medical engineering. 58(11):3197-205 [DOI] 10.1109/TBME.2011.2165713. [PMID] 21859595.
2011
Communication and Control System for a 15-Channel Hermetic Retinal Prosthesis.
Biomedical signal processing and control. 6(4):356-363 [PMID] 21927618.
2009
Extraction of a chronically implanted, microfabricated, subretinal electrode array.
Ophthalmic research. 42(3):128-37 [DOI] 10.1159/000227278. [PMID] 19590253.
2006
ChenElectrophysiological response in rabbits with normal and injured photoreceptor due to subretinal implantation of chip
. 22(5):324-327
2005
Subretinal implanting micro-chips for vision prosthesis
. 20(4):328-331
2001
A study on human vitreous rheology
. 19(5):405-406
2001
The variability of parameters in multi-focal electroretinograms
. 17(4):277-279
2001
Variability of mERG results
. 19(3):239-241
2000
Analysis and treatment of rehemorrhage in eyes with proliferative diabetic retinopathy after vitrectomy
. 18(2):83-84
1999
Macular hole on one high myopic eye induced by LASIK
. 35(4)

Grants

Feb 2024 ACTIVE
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF)
Role: Principal Investigator
Funding: JAEB CTR FOR HLTH RES via NATL INST OF HLTH NEI
May 2021 ACTIVE
A STUDY TO GENETICALLY DEFINE SUBJECTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Role: Principal Investigator
Funding: MEDPACE via GYROSCOPE THERAPEUTICS LIMITED

Education

Vitreoretinal Fellowship
2019 · University of Texas Southwestern Medical Center
PhD
1999 · People's Hospital of Peking University, Beijing, China
MD
1995 · Peking University Health Science Center, Beijing, China

Contact Details

Addresses:
Business Mailing:
P.O.BOX 100284
Dept.Of Ophthalmology
GAINESVILLE FL 32610-284
Business Street:
100393
100284
6201 W.Newberry Road-UF AT OAKS
Gainesville FL 32605